Management Team


Christian Horn

Founder of ScreenCancer. Responsible for international business development for 20 years in CEO/board positions in cancer detection focused companies. Led IPO of cancer diagnostics company at Oslo Stock Exchange (main list). BBA from the College of William & Mary, USA and Advanced Management &. Leadership Program, Oxford University.

Mette Valeur

General Manager at ScreenCancer and global operational and systems responsibility for the group. 20 years in leadership positions in insurance and customer centric organizations, incl. Dixons UK, Vesta and Skandia. MBA from Oslo Business School, and attended Harvard Business School, USA for Building & Leading Customer-Centric Organizations.
Head of US

Hans Gangeskar

Currently serves as Board Advisor, but very much engaged in the operations of DeepX Health. Plan to become CEO post funding and lead the company’s entry into the US. Gangeskar is co-founder and former CEO of Nurx, a US-based $300m telemedicine company, and is a graduate from Cambridge University.
Head of Product

Laurens Kraal

Dr. Kraal is the former head of product at a microbiome diagnostics company. Most recently, he served as a research fellow at the Berkeley Institute for Data Science. Dr. Kraal received his Ph.D from UCSF, during which he was also involved with multiple life-sciences startups. He also holds degrees from the University of Groningen, and a Utrecht University.

Dr. Kurt Ayerst

Medical Director and dermatology consultant with two decades of management experience. Chair of Dermatology Clinical Reference Group, NHS, the British Association of Dermatologists Skin Cancer Sub-committee.

Hans Hekland

As Managing Partner at Sarsia Venture Management, Hans has an extensive background from finance. He has also held positions as executive director at medical and life science-focused businesses as a venture capital investor. He has been actively involved in DeepX Health and its daughter companies, ScreenCancer and Balter Medical, since the establishment. His main areas of expertise include financial due diligence and finance, strategy and business development. He is a graduate from the Norwegian School of Economics and Business Administration.
Business Analyst

Knut Jacob Kartveit

Economics with Finance graduate from the University of Edinburgh. As a former intern at Novel Diagnostics, he has previous experience with the medical device industry and DeepX Health’s daughter company, ScreenCancer. His primary focus is on supporting the management team in making the correct business decisions, as well as on DeepX Health’s imminent fund-raising process.

Medical / Scientific Advisory Board

Dr. David Swanson

Associate Professor/Consultant at the Department of Dermatology at the Mayo Clinic (AZ, US). Engaged in dermatology-based research, Dr. Swanson’s primary research area is on noninvasive imaging technologies to diagnose skin cancer. Dr. Swanson holds a BA from Saint John’s University, and obtained his M.D. at the University of Minnesota Medical School.

Dr. Paola Pasquali

Dermatologist and specialist in skin cancer and noninvasive diagnosis techniques. Dr. Pasquali is a former President of the International Society of Teledermatology and Chairman of the International Affairs Committee of the American Academy of Dermatology and EADV School. In addition to being an internationally renowned speaker, Dr. Pasquali coordinates the Dermatology Service at Pius Hospital de Valls in the public sector. Dr. Pasquali is also the editor of four books, including Skin Cancer: A Practical Approach, Cryosurgery, A Practical Manual, Photography in Clinical Medicine and Textbook of Primary Care Dermatology.

Dr. Frank Castellana

Frank Castellana has held senior executive positions at Bristol-Myers Squibb, for both the Pharmaceutical and Medical Device Divisions. Prior to joining Bristol-Myers Squibb, he was associate professor of Chemical and Bioengineering at Columbia University and has a degree in Eng.Sc.D. Areas of expertise include product development and commercialization strategy, product and licensing transaction valuations, and portfolio strategy.

Dr. Rhonda Low

Dr. Low is Clinical Associate Professor in the Department of Family & Community Medicine at the University of British Columbia. She is also a fulltime practicing family physician in Vancouver and an executive health physician at Mayo Clinic in Arizona. She has a special interest in Continuing Medical Education for primary care practitioners, co-chairing one of the largest annual conferences in Canada. Dr Low is also a journalist. She was the health anchor for an evening newscast on a Canadian national affiliate television station for 15 years, has written regular health columns for local magazines, moderates community health events and is currently a regular medical commentator on television and radio

Prof. Knut Stamnes

Professor at the Department of Physics and Engineering Physics at Stevens Institute of Technology. Co-founder of Balter Medical and developed Balter Medical based on work done for NASA space agency. Specialist in Optical Transfer Diagnosis technology.

Dr. Herbert Kirchesch

Dr. Kirchesch has more than 3 decades of experience in dermatology. He runs his own dermtaology clinic in Cologne/Pulheim Germany, where he has practiced dermatology since the nineties. Besides his interest in Dermatology and Allergology, his main fields of interest are skin cancer and optical tools for its detection. Dr. Kirchesch has also contributed to several scientific publications, organized congresses and seminars for dermatology, and is supporting the German Albinism ngo as medical consultant.

Prof. Jakob Stamnes

Co-founder of Balter Medical, and specialist in Optical Transfer Diagnosis technology. Professor Emeritus of Physics at the University of Bergen, with more than 200 publications.

Commercial Advisory Board

Xavier Yon

Xavier Yon is an experienced healthcare executive with an extensive background in dermatology. Previous roles include executive positions with Pfizer, Solvay, Alcon and most notably as Chief Executive Officer of Galderma for 17 years.

Giovanni Monti

Senior healthcare executive with extensive experience in leading innovative, tech-enabled healthcare services and award-winning digital health products and platforms in the US and Europe. Senior Vice President of Healthcare Services at Walgreens Boots Alliance, board member of the Health Division of the Consumer Technology Association and of health tech investments.

David Nikka

Former COO of Exact Sciences. Broadly experienced senior executive in diagnostics, medical devices and pharmaceuticals at companies including Dermira, Abiomed and Genzyme with responsibilities for corporate and product development, regulatory, clinical affairs, human resources and division general management. Co-founder of ScreenCancer, Inc.

Ben Kent

Ben has held a range of executive positions in the healthcare sector, including CFO and COO of Doctor Care Anywhere, CFO of Simplyhealth, Group Director of Finance at Bupa, and interim CFO of DeepX Health. Ben is a graduate of the University of Oxford and Chartered Accountant.